Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 330

1.

The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis.

Boyle DL, Soma K, Hodge J, Kavanaugh A, Mandel D, Mease P, Shurmur R, Singhal AK, Wei N, Rosengren S, Kaplan I, Krishnaswami S, Luo Z, Bradley J, Firestein GS.

Ann Rheum Dis. 2014 Nov 14. pii: annrheumdis-2014-206028. doi: 10.1136/annrheumdis-2014-206028. [Epub ahead of print]

PMID:
25398374
[PubMed - as supplied by publisher]
Free Article
2.

Proceedings from the ACR Reproductive Health Summit: The management of fertility, pregnancy and lactation in women with autoimmune and systemic inflammatory diseases.

Kavanaugh A, Cush JJ, Ahmed MS, Bermas BL, Chakravarty E, Chambers C, Clowse M, Curtis JR, Dao K, Hankins GD, Koren G, Kim SC, Lapteva L, Mahadevan U, Moore T, Nolan M, Ren Z, Sammaritano LR, Seymour S, Weisman MH.

Arthritis Care Res (Hoboken). 2014 Nov 10. doi: 10.1002/acr.22516. [Epub ahead of print] No abstract available.

PMID:
25385050
[PubMed - as supplied by publisher]
3.

Optimisation of assessment for rheumatic diseases in clinical trials, observational studies and routine clinical care.

Pincus T, Braun J, Kavanaugh A, Smolen JS.

Clin Exp Rheumatol. 2014 Sep-Oct;32 Suppl 85(5):1. Epub 2014 Oct 30.

PMID:
25365080
[PubMed - as supplied by publisher]
4.

Treatments for Nail Psoriasis: A Systematic Review by the GRAPPA Nail Psoriasis Work Group.

Armstrong AW, Tuong W, Love TJ, Carneiro S, Grynszpan R, Lee SS, Kavanaugh A.

J Rheumatol. 2014 Nov;41(11):2306-14. doi: 10.3899/jrheum.140881.

PMID:
25362716
[PubMed - in process]
5.

Systematic Review of Treatments for Psoriatic Arthritis: 2014 Update for the GRAPPA.

Coates LC, Kavanaugh A, Ritchlin CT; GRAPPA Treatment Guideline Committee.

J Rheumatol. 2014 Nov;41(11):2273-6. doi: 10.3899/jrheum.140875.

PMID:
25362710
[PubMed - in process]
6.

A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of 2 Dosing Regimens of Fostamatinib in Patients with Rheumatoid Arthritis with an Inadequate Response to a Tumor Necrosis Factor-α Antagonist.

Genovese MC, van der Heijde DM, Keystone EC, Spindler AJ, Benhamou C, Kavanaugh A, Fudman E, Lampl K, O'Brien C, Duffield EL, Poiley J, Weinblatt ME.

J Rheumatol. 2014 Nov;41(11):2120-8. doi: 10.3899/jrheum.140238. Epub 2014 Sep 15.

PMID:
25225285
[PubMed - in process]
7.

Effects of Fostamatinib, an Oral Spleen Tyrosine Kinase Inhibitor, in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate: Results From a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study.

Weinblatt ME, Genovese MC, Ho M, Hollis S, Rosiak-Jedrychowicz K, Kavanaugh A, Millson DS, Leon G, Wang M, van der Heijde D.

Arthritis Rheumatol. 2014 Dec;66(12):3255-64. doi: 10.1002/art.38851.

PMID:
25223724
[PubMed - in process]
8.

Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics.

Dennis G Jr, Holweg CT, Kummerfeld SK, Choy DF, Setiadi AF, Hackney JA, Haverty PM, Gilbert H, Lin WY, Diehl L, Fischer S, Song A, Musselman D, Klearman M, Gabay C, Kavanaugh A, Endres J, Fox DA, Martin F, Townsend MJ.

Arthritis Res Ther. 2014;16(2):R90. Epub 2014 Apr 30.

PMID:
25167216
[PubMed - in process]
Free PMC Article
9.

Comprehensive disease control (CDC): what does achieving CDC mean for patients with rheumatoid arthritis?

Emery P, Kavanaugh A, Bao Y, Ganguli A, Mulani P.

Ann Rheum Dis. 2014 Aug 19. pii: annrheumdis-2014-205302. doi: 10.1136/annrheumdis-2014-205302. [Epub ahead of print]

PMID:
25139667
[PubMed - as supplied by publisher]
Free Article
10.

Psoriatic arthritis: current therapy and future approaches.

Huynh D, Kavanaugh A.

Rheumatology (Oxford). 2014 Aug 14. pii: keu237. [Epub ahead of print] Review.

PMID:
25125588
[PubMed - as supplied by publisher]
11.

Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example.

Landewé RB, Smolen JS, Weinblatt ME, Emery P, Dougados M, Fleischmann R, Aletaha D, Kavanaugh A, van der Heijde D.

Ann Rheum Dis. 2014 Oct;73(10):1755-60. doi: 10.1136/annrheumdis-2014-205821. Epub 2014 Aug 11.

PMID:
25114058
[PubMed - in process]
12.

A review of disease activity measures for psoriatic arthritis: what is the best approach?

Her M, Kavanaugh A.

Expert Rev Clin Immunol. 2014 Sep;10(9):1241-54. doi: 10.1586/1744666X.2014.943663. Epub 2014 Aug 4.

PMID:
25088300
[PubMed - in process]
13.

Qualifying unmet needs and improving standards of care in psoriatic arthritis.

Helliwell P, Coates L, Chandran V, Gladman D, de Wit M, FitzGerald O, Kavanaugh A, Strand V, Mease PJ, Boehncke WH, Langley RG, Lubrano E, Maccarone M, Schulze-Koops H, Miceli-Richard C, Queiro R.

Arthritis Care Res (Hoboken). 2014 Dec;66(12):1759-66. doi: 10.1002/acr.22404. No abstract available.

PMID:
25047391
[PubMed - in process]
Free Article
14.

Novel treatments with small molecules in psoriatic arthritis.

Hansen RB, Kavanaugh A.

Curr Rheumatol Rep. 2014 Sep;16(9):443. doi: 10.1007/s11926-014-0443-6.

PMID:
25027606
[PubMed - in process]
15.

Improvements in productivity at paid work and within the household, and increased participation in daily activities after 24 weeks of certolizumab pegol treatment of patients with psoriatic arthritis: results of a phase 3 double-blind randomised placebo-controlled study.

Kavanaugh A, Gladman D, van der Heijde D, Purcaru O, Mease P.

Ann Rheum Dis. 2014 Jun 18. pii: annrheumdis-2014-205198. doi: 10.1136/annrheumdis-2014-205198. [Epub ahead of print]

PMID:
24942382
[PubMed - as supplied by publisher]
Free Article
16.

GRAPPA treatment recommendations: an update from the GRAPPA 2013 Annual Meeting.

Coates LC, Ritchlin CT, Kavanaugh AF.

J Rheumatol. 2014 Jun;41(6):1237-9. doi: 10.3899/jrheum.140179.

PMID:
24882861
[PubMed - in process]
17.

Clinical question: are non-steroidal anti-inflammatories superior to acetaminophen for sprains/strains?

Wheeler H, Vonfeldt K, Kavanaugh A, Owens T.

J Okla State Med Assoc. 2014 Mar;107(3):109-10. Review. No abstract available.

PMID:
24800464
[PubMed - indexed for MEDLINE]
18.

Clinical efficacy, radiographic and safety findings through 5 years of subcutaneous golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of a randomised, placebo-controlled trial (the GO-REVEAL study).

Kavanaugh A, McInnes IB, Mease P, Krueger GG, Gladman D, van der Heijde D, Zhou Y, Lu J, Leu JH, Goldstein N, Beutler A.

Ann Rheum Dis. 2014 Sep;73(9):1689-94. doi: 10.1136/annrheumdis-2013-204902. Epub 2014 Apr 19.

PMID:
24748630
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis.

Kavanaugh A, Wells AF.

Rheumatology (Oxford). 2014 Oct;53(10):1742-51. doi: 10.1093/rheumatology/keu135. Epub 2014 Apr 10.

PMID:
24729402
[PubMed - in process]
Free PMC Article
20.

Editorial: pregnancy and rheumatoid arthritis - do not let the perfect become the enemy of the good.

Cush JJ, Kavanaugh A.

Curr Opin Rheumatol. 2014 May;26(3):299-301. doi: 10.1097/BOR.0000000000000061. No abstract available.

PMID:
24667288
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk